Latest Sofinnova Investments, Inc. Stock Portfolio
Sofinnova Investments, Inc. Performance:
2024 Q3: 5.81%YTD: 16.76%2023: 6.35%
Performance for 2024 Q3 is 5.81%, and YTD is 16.76%, and 2023 is 6.35%.
About Sofinnova Investments, Inc. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Sofinnova Investments, Inc. reported an equity portfolio of $1.3 Billions as of 30 Sep, 2024.
The top stock holdings of Sofinnova Investments, Inc. are NTRA, VERA, . The fund has invested 15.6% of it's portfolio in NATERA INC and 9.8% of portfolio in VERA THERAPEUTICS INC.
The fund managers got completely rid off ASCENDIS PHARMA A/S, STRYKER CORPORATION (SYK) and ALIGN TECHNOLOGY INC (ALGN) stocks. They significantly reduced their stock positions in TG THERAPEUTICS INC (TGTX), EXACT SCIENCES CORP (EXAS) and EDWARDS LIFESCIENCES CORP (EW). Sofinnova Investments, Inc. opened new stock positions in BIOAGE LABS INC, INCYTE CORP (INCY) and JAZZ PHARMACEUTICALS PLC (JAZZ). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, IDEAYA BIOSCIENCES INC (IDYA) and AVIDITY BIOSCIENCES INC (RNA).
The top stock holdings of Sofinnova Investments, Inc. are NTRA, VERA, . The fund has invested 15.6% of it's portfolio in NATERA INC and 9.8% of portfolio in VERA THERAPEUTICS INC.
The fund managers got completely rid off ASCENDIS PHARMA A/S, STRYKER CORPORATION (SYK) and ALIGN TECHNOLOGY INC (ALGN) stocks. They significantly reduced their stock positions in TG THERAPEUTICS INC (TGTX), EXACT SCIENCES CORP (EXAS) and EDWARDS LIFESCIENCES CORP (EW). Sofinnova Investments, Inc. opened new stock positions in BIOAGE LABS INC, INCYTE CORP (INCY) and JAZZ PHARMACEUTICALS PLC (JAZZ). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, IDEAYA BIOSCIENCES INC (IDYA) and AVIDITY BIOSCIENCES INC (RNA).
Sofinnova Investments, Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Sofinnova Investments, Inc. made a return of 5.81% in the last quarter. In trailing 12 months, it's portfolio return was 31.48%.
New Buys
| Ticker | $ Bought |
|---|---|
| bioage labs inc | 47,941,900 |
| incyte corp | 47,207,000 |
| jazz pharmaceuticals plc | 21,007,700 |
| rhythm pharmaceuticals | 14,495,200 |
| guardant health inc | 9,328,440 |
| janux therapeutics inc | 7,485,500 |
| illumina inc | 5,296,080 |
| becton dickinson & co | 3,662,550 |
New stocks bought by Sofinnova Investments, Inc.
Additions
| Ticker | % Inc. |
|---|---|
| structure therapeutics inc | 335 |
| ideaya biosciences inc | 51.92 |
| avidity biosciences inc | 42.23 |
| disc medicine inc | 41.35 |
| astria therapeutics inc | 41.11 |
| insmed inc | 25.71 |
| cabaletta bio inc | 25.69 |
| elanco animal health inc | 22.85 |
Additions to existing portfolio by Sofinnova Investments, Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| tg therapeutics inc | -80.73 |
| exact sciences corp | -79.3 |
| edwards lifesciences corp | -71.98 |
| kura oncology inc | -64.02 |
| syndax pharmaceuticals inc | -63.46 |
| establishment labs hldgs inc | -57.72 |
| revolution medicines inc | -55.33 |
| dyne therapeutics inc | -52.51 |
Sofinnova Investments, Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| roivant sciences ltd | -19,749,100 |
| ascendis pharma a/s | -100,142,000 |
| pepgen inc | -8,955,600 |
| celldex therapeutics inc | -20,270,600 |
| 4d molecular therapeutics inc | -5,691,540 |
| align technology inc | -52,758,200 |
| sarepta therapeutics inc | -30,944,600 |
| stryker corporation | -65,696,800 |
Sofinnova Investments, Inc. got rid off the above stocks
Sector Distribution
Sofinnova Investments, Inc. has about 74.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 74.5 |
| Others | 25.5 |
Market Cap. Distribution
Sofinnova Investments, Inc. has about 24.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 30.4 |
| UNALLOCATED | 25.5 |
| LARGE-CAP | 24.9 |
| SMALL-CAP | 16.4 |
| MICRO-CAP | 1.3 |
| NANO-CAP | 1.1 |
Stocks belong to which Index?
About 47% of the stocks held by Sofinnova Investments, Inc. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 53 |
| RUSSELL 2000 | 40 |
| S&P 500 | 7 |
Sofinnova Investments, Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Sofinnova Investments, Inc.
Sofinnova Investments, Inc. has 57 stocks in it's portfolio. About 59.8% of the portfolio is in top 10 stocks. EW proved to be the most loss making stock for the portfolio. NTRA was the most profitable stock for Sofinnova Investments, Inc. last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACHV | achieve life sciences inc | 0.57 | 1,514,030 | 7,176,510 | added | 9.05 | ||
| ALGN | align technology inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALNY | alnylam pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXS | astria therapeutics inc | 0.07 | 85,640 | 942,896 | added | 41.11 | ||
| AVTE | aerovate therapeutics inc | 0.62 | 3,758,690 | 7,855,650 | unchanged | 0.00 | ||
| AVTR | avantor inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXNX | axonics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 2.71 | 379,527 | 34,108,100 | added | 22.35 | ||
| BAX | baxter intl inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BDX | becton dickinson & co | 0.29 | 15,191 | 3,662,550 | new | |||
| BOLT | bolt biotherapeutics inc | 0.14 | 2,754,440 | 1,784,880 | unchanged | 0.00 | ||
| BSX | boston scientific corp | 0.90 | 135,819 | 11,381,600 | reduced | -20.61 | ||
| CABA | cabaletta bio inc | 0.58 | 1,533,880 | 7,239,930 | added | 25.69 | ||
| CLDX | celldex therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| COGT | cogent biosciences inc | 1.94 | 2,265,230 | 24,464,500 | reduced | -18.32 | ||
| DXCM | dexcom inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DYN | dyne therapeutics inc | 2.20 | 772,070 | 27,732,800 | reduced | -52.51 | ||
| ELAN | elanco animal health inc | 4.10 | 3,518,680 | 51,689,500 | added | 22.85 | ||
| ERAS | erasca inc | 0.40 | 1,842,670 | 5,030,480 | added | 8.42 | ||
| ESTA | establishment labs hldgs inc | 0.62 | 181,476 | 7,852,470 | reduced | -57.72 | ||